- Record: found
- Abstract: not found
- Article: not found
Lenalidomide maintenance after first-line therapy for high-risk chronic lymphocytic leukaemia (CLLM1): final results from a randomised, double-blind, phase 3 study
Anna Maria Fink ,
Jasmin Bahlo ,
Sandra Robrecht ,
Othman Al-Sawaf ,
Ali Aldaoud ,
Holger Hebart ,
Kathleen Jentsch-Ullrich ,
Steffen Dörfel ,
Kirsten Fischer ,
Clemens-Martin Wendtner ,
Thomas Nösslinger ,
Paolo Ghia ,
Francesc Bosch ,
Arnon P Kater ,
Hartmut Döhner ,
Michael Kneba ,
Karl-Anton Kreuzer ,
Eugen Tausch ,
Stephan Stilgenbauer ,
Matthias Ritgen ,
Sebastian Böttcher ,
Barbara Eichhorst ,
Michael Hallek
October 2017
October 2017
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.